SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
-9.51%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.44B
AUM Growth
+$1.44B
(-5%)
Cap. Flow
+$114M
Cap. Flow
% of AUM
7.93%
Top 10 Holdings %
Top 10 Hldgs %
59.95%
Holding
66
New
13
Increased
16
Reduced
8
Closed
9
Top Buys
| 1 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
$53.7M |
| 2 |
Elanco Animal Health
ELAN
|
$40.6M |
| 3 |
Sanofi
SNY
|
$37.3M |
| 4 |
Kenvue
KVUE
|
$36.2M |
| 5 |
Merck
MRK
|
$20.7M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$51.1M |
| 2 |
Exelixis
EXEL
|
$37.8M |
| 3 |
Boston Scientific
BSX
|
$32.9M |
| 4 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$32.9M |
| 5 |
AstraZeneca
AZN
|
$22.7M |
Sector Composition
| 1 | Healthcare | 94.38% |
| 2 | Consumer Staples | 2.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alkermes
ALKS
$4.95B
| $15.1M | 0.95% |
+537,464
| New | +$15.1M |
|
27
Syndax Pharmaceuticals
SNDX
$1.39B
| $13.7M | 0.86% |
941,817
-640,474
| -40% | -$9.3M |
|
|
INBX
28
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $13.6M | 0.86% |
743,294
-254,989
| -26% | -$4.68M |
|
29
Y-mAbs Therapeutics
YMAB
$390M
| $12M | 0.75% |
2,194,278
| – | – |
|
30
Celldex Therapeutics
CLDX
$1.57B
| $11.7M | 0.74% |
424,259
+226,501
| +115% | +$6.23M |
|
31
Structure Therapeutics
GPCR
$1.14B
| $10.2M | 0.64% |
+202,119
| New | +$10.2M |
|
32
Replimune Group
REPL
$460M
| $8.62M | 0.54% |
503,844
+154,955
| +44% | +$2.65M |
|
|
MRNS
33
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $7.93M | 0.5% |
985,606
+22,987
| +2% | +$185K |
|
34
Geron
GERN
$893M
| $7.85M | 0.5% |
3,702,546
-1,726,609
| -32% | -$3.66M |
|
35
Dyne Therapeutics
DYN
$1.92B
| $6.14M | 0.39% |
685,133
+244,085
| +55% | +$2.19M |
|
36
Axsome Therapeutics
AXSM
$6.09B
| $5.62M | 0.35% |
80,368
-98,874
| -55% | -$6.91M |
|
37
Immunovant
IMVT
$2.91B
| $5.37M | 0.34% |
+139,885
| New | +$5.37M |
|
38
NextCure
NXTC
$13.3M
| $3.45M | 0.22% |
2,671,856
| – | – |
|
|
NCNA
39
NuCana
NCNA
$5.8M
| $3.42M | 0.22% |
5,599,999
| – | – |
|
40
Bolt Biotherapeutics
BOLT
$9.29M
| $2.86M | 0.18% |
2,754,437
| – | – |
|
|
IMTXW
41
DELISTED
Immatics N.V. Warrants
IMTXW
| $1.13M | 0.07% |
+318,896
| New | +$1.13M |
|
42
Stryker
SYK
$149B
| $896K | 0.06% |
+3,279
| New | +$896K |
|
43
PDS Biotechnology
PDSB
$60.6M
| $720K | 0.05% |
142,635
| – | – |
|
44
Savara
SVRA
$591M
| $597K | 0.04% |
157,908
+61,660
| +64% | +$233K |
|
|
GRTX
45
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $540K | 0.03% |
3,083,712
| – | – |
|
|
IMA
46
ImageneBio, Inc. Common Stock
IMA
$153M
| $501K | 0.03% |
+115,712
| New | +$501K |
|
|
FUSN
47
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $304K | 0.02% |
117,099
| – | – |
|
48
Mirum Pharmaceuticals
MIRM
$3.75B
| $287K | 0.02% |
9,089
| – | – |
|
|
SPRB
49
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $131K | 0.01% |
58,029
| – | – |
|
50
Synlogic
SYBX
$17.4M
| $108K | 0.01% |
38,331
-536,641
| -93% | – |
|